(Q36528654)

14 August 2017

1 reference

title

Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism (English)

1 reference

high-performance liquid chromatography

14 August 2017

1 reference

2

Enrico Domenici

1 reference

14 August 2017

1

Giorgio A Ascoli

1 reference

14 August 2017

Carlo Bertucci

3

1 reference

14 August 2017

1 September 2006

1 reference

14 August 2017

1 reference

14 August 2017

18

1 reference

14 August 2017

9

1 reference

14 August 2017

667-679

1 reference

Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance

14 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

The role of albumin in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Clinically important drug interactions with anticoagulants. An update

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Human serum albumin as a 'silent receptor' for drugs and endogenous substances

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Structural basis of the drug-binding specificity of human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Atomic structure and chemistry of human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Crystal structure of human serum albumin at 2.5 A resolution

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Complete amino acid sequence of human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Synthesis and chromatographic properties of an HPLC chiral stationary phase based upon human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Ligand binding to a human serum albumin stationary phase: use of same-drug competition to discriminate pharmacologically relevant interactions

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

High-performance affinity chromatography: a powerful tool for studying serum protein binding

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

The measurement of binding constants using circular dichroism. Binding of phenylbutazone and oxyphenbutazone

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Stereospecific and competitive binding of drugs to human serum albumin: a difference circular dichroism approach.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Biosensor Analysis of the Interaction between Immobilized Human Serum Albumin and Drug Compounds for Prediction of Human Serum Albumin Binding Levels

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Tech.Sight. Analyzing biomolecular interactions

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Characterizing a drug's primary binding site on albumin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Early Absorption and Distribution Analysis of Antitumor and Anti-AIDS Drugs: Lipid Membrane and Plasma Protein Interactions

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Resolution of DL-Tryptophan by Affinity Chromatography on Bovine-Serum Albumin-Agarose Columns

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Binding of some fatty acids and drugs to immobilized bovine serum albumin studied by column affinity chromatography

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Resolution by affinity chromatography: stereoselective binding of racemic oxazepam esters to human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

High-performance affinity monolith chromatography: development and evaluation of human serum albumin columns

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Characterization of the binding and chiral separation of D- and L-tryptophan on a high-performance immobilized human serum albumin column

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Characterization of the protein binding of chiral drugs by high-performance affinity chromatography. Interactions of R- and S-ibuprofen with human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Immobilized serum albumin: Rapid HPLC probe of stereoselective protein-binding interactions

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Enantioselective inhibition of the binding of rac-profens to human serum albumin induced by lithocholate

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Stereochemical features of 1,4-benzodiazepin-2-ones bound to human serum albumin: difference CD and UV studies

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Use of a Human Serum Albumin-Based High-Performance Liquid Chromatography Chiral Stationary Phase for the Investigation of Protein Binding: Detection of the Allosteric Interaction between Warfarin and Benzodiazepine Binding Sites

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Stereoselective binding of 3-acetoxy-, and 3-hydroxy-1,4-benzodiazepine-2-ones to human serum albumin. Selective allosteric interaction with warfarin enantiomers.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Site I on human albumin: differences in the binding of (R)- and (S)-warfarin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Improved chromatographic performance of a modified human albumin based stationary phase

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Chemical modification of human albumin at cys34 by ethacrynic acid: structural characterisation and binding properties.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Reversible binding of ethacrynic acid to human serum albumin: difference circular dichroism study.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

The location of drug binding sites in human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Protein binding investigation by difference circular dichroism: native and acetylated human serum albumins.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

The binding of 5-fluorouracil to native and modified human serum albumin: UV, CD, and 1H and 19F NMR investigation

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

General approach to chiroptical characterization of binding of prochiral and chiral 1,4-benzodiazepin-2-ones to human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Circular dichroism and gel filtration study of binding of prochiral and chiral 1,4-benzodiazepin-2-ones to human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Information content in the circular dichroism of proteins.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Structural mechanism of the simultaneous binding of two drugs to a multidrug-binding protein

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Specific ligand binding on genetic variants of human alpha1-acid glycoprotein studied by circular dichroism spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20301

7 January 2021

Identifiers

DOI

10.1002/CHIR.20301

1 reference

14 August 2017

1 reference

PubMed ID

16823814